why choose us

First received: December 12, 2022

Clinical Trial: Safety Study of OA-235i in Subjects With Nonalcoholic Steatohepatitis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Nonalcoholic Steatohepatitis

Study Type: INTERVENTIONAL


Official Title: A Phase 1a/1b Single Ascending and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OA-235i, a PAR2 Inhibitor, in Adults With Nonalcoholic Steato

Brief Summary: This study is a Phase 1, first-in-human single-dose escalation study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of OA-235i in subjects with nonalcoholic steatohepatitis.

Read more